Live Breaking News & Updates on Prnewswire Radiopharm Theranostics

Stay updated with breaking news from Prnewswire radiopharm theranostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL

/PRNewswire/ Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a developer of a world-class platform of radiopharmaceutical products for. ....

City Of , United Kingdom , Comunidad Autonoma De Cataluna , Eric Aboagye , Radiopharm Theranostics , Paul Hopper , Prnewswire Radiopharm Theranostics , Riccardo Canevari , Matt Wright , Imperial College London , Research Council , Cancer Research Technology , Research Agreement , Medical Research Council , Professor Eric Aboagye , Cancer Research Technology Limited , Sponsored Research Agreement , Executive Chairman Paul ,

RADIOPHARM ENTERS INTO STRATEGIC COLLABORATION WITH LANTHEUS AND ASSUMES PD-L1 LICENSING AGREEMENT FROM NANOMAB

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

United States , Radiopharm Theranostics , Paul Hopper , Prnewswire Radiopharm Theranostics , Riccardo Canevari , Etienne Montagut , Nanomab Ltd , Drug Administration , United States Food , Director Riccardo Canevari , Chief Business Officer , Chairman Paul , Pr Newswire , Licensing Agreements ,